Reuters logo
7 months ago
BRIEF-RIBOMIC in discussion to continue joint research with Otsuka Pharmaceutical on RBM001
January 11, 2017 / 6:26 AM / 7 months ago

BRIEF-RIBOMIC in discussion to continue joint research with Otsuka Pharmaceutical on RBM001

Jan 11 (Reuters) - RIBOMIC Inc :

* Says co is in discussion to continue joint research with Otsuka Pharmaceutical Co Ltd on RBM001 (midkine aptamers targeted)

* The former cooperation agreement have expired since Dec. 2016

Source text in Japanese: goo.gl/FtLNsY

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below